Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de David F. Hale
Leeftijd : 72
Vermogen : 32 936 594 USD
Belangrijkste bedrijven : Oncternal Therapeutics, Inc. - Biocept, Inc. - Dermata Therapeutics, Inc.
Overzicht 
Mr. David F. Hale is a Chairman at Dermata Therapeutics LLC, a Chairman at Recros Medica, Inc., an Executive Chairman at MDRejuvena, Inc., a Non-Executive Chairman at Biocept, Inc., a Chairman at Advantar Laboratories, Inc., a Chairman & Chief Executive Officer at Hale BioPharma Ventures LLC, a Chairman at Oncternal Therapeutics, Inc., an Advisor at Windamere Venture Partners LLC, a Chairman at Intrepid Therapeutics, Inc., a Chairman at Rady Children's Institute for Genomic Medicine, a Chairman at Rich Diagnostics, Inc., a Chairman at Ridge Diagnostics, Inc., a Chairman at Zerigo Health, Inc., an Executive Chairman at Neurana Pharmaceuticals, Inc. and a General Partner at Hale Trading Co. LP.

He is on the Board of Directors at Adigica Health, Inc., Neurelis, Inc., BIOCOM, Idun Pharmaceuticals, Inc., San Diego Regional Economic Development Corp., Rady Children's Hospital & Health Center of San Diego and The Salk Institute for Biological Studies. Mr. Hale was previously employed as an Independent Non-Executive Director by Cassiopea SpA, a Chairman by Agility Clinical, Inc., a Chairman by Conatus Pharmaceuticals, Inc., a Non-Executive Chairman by Somaxon Pharmaceuticals, Inc., a Chairman by SkinMedica, Inc., a Chairman by Santarus, Inc., a Chairman by Micromet, Inc., a Chairman by CancerVax Corp., a President & Chief Executive Officer by Women First HealthCare, Inc., an Executive Chairman & Chief Executive Officer by Metabasis Therapeutics, Inc., a Chairman, President & Chief Executive Officer by Gensia-Sicor, Inc., a Chairman by Viagene, Inc., a President, Chief Executive & Operating Officer by Hybritech, Inc., a General Manager & Vice President by BBL Microbiology Systems, a VP & General Manager-BBL Microbiology Systems by Becton, Dickinson & Co., a Trustee by CONNECT, a Chairman by CRISI Medical Systems, Inc., a Chairman by Oncternal Oncology, Inc., and a Principal by Ortho Pharmaceutical Corp.

He also served on the board at Verus Pharmaceuticals, Inc.,


Posities en verantwoordelijkheden van David F. Hale 
NaamTitel Van
Oncternal Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Chairman 2018
Biocept, Inc.
(Medische apparatuur, benodigdheden & distributie)
Director -
Dermata Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Lead Independent Director 2021
Hale BioPharma Ventures LLC Chairman & Chief Executive Officer 2006
Zerigo Health, Inc. Chairman 2020
Ridge Diagnostics, Inc. Chairman -
Rich Diagnostics, Inc. Chairman -
Eurofins Advantar Laboratories, Inc. Chairman 2008
Intrepid Therapeutics, Inc. Chairman -
Rady Children's Institute for Genomic Medicine Chairman -
The Salk Institute for Biological Studies Trustee -
Idun Pharmaceuticals, Inc. Director -
MDRejuvena, Inc. Executive Chairman 2013
Rady Children's Hospital & Health Center of San Diego Trustee 1986
BIOCOM Director 1995
San Diego Regional Economic Development Corp. Director -
Neurelis, Inc. Director -
Adigica Health, Inc. Director 2016
Neurana Pharmaceuticals, Inc. Executive Chairman -
Hale Trading Co. LP General Partner -


Belangnemingen van David F. Hale 
NaamAandelen%Totale waarde
Dermata Therapeutics, Inc. (DRMA)
(Biotechnologie & Medisch Onderzoek)
5 673 65468,1%32 907 193 USD
Biocept, Inc. (BIOC)
(Medische apparatuur, benodigdheden & distributie)
4 4560,030%16 131 USD
Histogen Inc. (HSTO)
(Biotechnologie & Medisch Onderzoek)
16 7980,040%13 270 USD
Oncternal Therapeutics, Inc. (ONCT)
(Biotechnologie & Medisch Onderzoek)
00,0000%0 USD


David F. HalePersoonlijk netwerk 
Meest gelezen nieuws 
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
13/09MARTIN SORRELL : Sorrell's S4 Capital verhoogt winstverwachting tot 40%
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
David F. Hale Verbindingen